Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Index In Focus: A50 Bears In Control As COVID Spreads In China

Published 04/27/2022, 12:15 AM
Updated 07/09/2023, 06:31 AM

Why the COVID outbreak across the country may well get worse before it gets better...

Global fear toward Chinese assets is growing increasingly palpable.

As my colleague Fawad Razaqzada noted yesterday, the yuan has fallen to 17-month lows near 6.60, representing a more than 3% rise in the normally low-volatility pairing of the world’s two largest economies, but the selling has been even more dramatic in equity indices.

Looking at the FTSE China A50 Index of domestic shares, prices are down nearly -40% from their highs in Q1 2021 and more than -20% from the peak in mid-December; this is among the worst returns of all global indices so far this year. While there are multiple catalysts for the continued downtrend, including a crackdown on technology companies, a real estate slump, and general risk aversion from the ongoing Russia-Ukraine conflict, the biggest issue for traders right now is the ongoing outbreak of COVID in the country.

The manufacturing and financial hub of Shanghai has been in lockdown for nearly a month, forcing businesses to close and exacerbating the global supply chain disruption. Now, traders are concerned that the same fate may befall Beijing after city authorities announced that the virus may have been spreading in the capital for the last week, characterizing the situation as “urgent and grim.” With no imminent signs that Chinese political leaders will change the country’s “zero tolerance” policy and cases still on the rise, the outbreak across the country may well get worse before it gets better.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Technical view: FTSE China A50

As the chart below shows, the A50 index has been trending lower since peaking above 20,000 last February, reaching a low near the 78.6% Fibonacci retracement of the 2019-2021 rally around 12,400 last month. After consolidating below the 14,000 level for the past five weeks, the index has rolled over again this week and may soon re-test the multi-year lows.

FTSE China A50 Index Chart

Source: TradingView, StoneX

As the RSI indicator in the lower pane shows, prices remain firmly in oversold territory but are no longer oversold, hinting at another leg lower from here. If the two-year low at 12,400 gives way, bears may look to target COVID lows at 11,750 next. Meanwhile, traders will likely be looking for a move back above the 50-day EMA and previous highs in the 14,000 area before growing more confident that the downtrend may be coming to an end.

Original Post

Latest comments

Hi Im sorif fanik
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.